Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may trigger sudden temporary hair loss.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

Starving yourself can cause hair loss, but stopping the diet can improve it.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Eating too much or too little vitamin A can cause hair loss.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Low iron levels are linked to hair loss in women.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

A rare scalp infection in a 66-year-old woman was successfully treated, leading to full hair regrowth.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Low iron and vitamin B12 levels are common in women with chronic hair loss, while low vitamin D is less common.

The supplement significantly improves hair density and appearance in people with hair loss.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.